Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
40 participants
OBSERVATIONAL
2023-12-18
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Ultrasonic Noise Exposure on Human Hearing
NCT03515928
The Effect of Binaural Auditory Beats on Hand-Eye Coordination in Adult Population
NCT06182813
Brain Imaging of Tinnitus
NCT00359931
Automated Measures of Speech Intelligibility Using Brain Wave Recordings
NCT06402994
Exploiting the Potential of Neural Attentional Control to Overcome Hearing Impairment
NCT05513352
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To do this we need people with different hearing levels to participate in our study. Including people with normal hearing and people with a hearing loss. We aim to recruit nearly 40 people in total with a range of different hearing levels.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal Hearing Group
Participants with hearing levels of 20dBHL or better at 6 and 8kHz frequencies of sound
No intervention
There is no intervention this is an observational study to develop a diagnostic test
Mild Hearing Loss Group
Participants with hearing levels of 25-40dBHL at 6 and 8kHz frequencies of sound
No intervention
There is no intervention this is an observational study to develop a diagnostic test
Moderate Hearing Loss Group
Participants with hearing levels of 45-70dBHL at 6 and 8kHz frequencies of sound
No intervention
There is no intervention this is an observational study to develop a diagnostic test
Severe Hearing Loss Group
Participants with hearing levels of 75- 90dBHL at 6 and 8kHz frequencies of sound
No intervention
There is no intervention this is an observational study to develop a diagnostic test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
There is no intervention this is an observational study to develop a diagnostic test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant is over 18.
* Hearing in the test ear of ≤90dBSPL at 6 kHz and 8 kHz in PTA
* Able and willing to perform PTA reliably.
* Able and willing to sit still comfortably for the duration of an ABR.
Exclusion Criteria
* Occluding wax, TM perforations or ear infections (on otoscopy)
* CI or BAHA user
* Abnormal outer of middle ear
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manchester
OTHER
Cardiff and Vale University Health Board
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiff and Value University Health Board
Cardiff, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Research and Development
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
32889
Identifier Type: OTHER
Identifier Source: secondary_id
8537
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.